Shukla Sanjay, President and CEO of aTYR Pharma ($ATYR), made one open market sale of company shares in the last year, totaling $3,655. His most recent transaction occurred on February 4, 2026. Among 11,678 insiders with sales, his activity ranks 11,443rd by value, well below the average of $8.6 million across about 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Common Stock | 10375 | $0.00 | 157,298.0000 | 97,986,634 | 7.06% | 0.01% |
| Feb. 3, 2026 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Restricted Stock Unit | 10375 | $0.00 | 0.0000 | 97,986,634 | 100.00% | 0.01% |
| Feb. 4, 2026 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | S | Common Stock | 3745 | $0.98 | 153,553.0000 | 97,986,634 | 2.38% | 0.00% |
| Jan. 9, 2026 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | A | Employee Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 97,986,634 | 9999.99% | 1.53% |
| Feb. 3, 2025 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Common Stock | 10375 | $0.00 | 146,923.0000 | 0 | 7.60% | 0.00% |
| Feb. 3, 2025 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Restricted Stock Unit | 10375 | $0.00 | 10,375.0000 | 0 | 50.00% | 0.00% |
| Jan. 8, 2025 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | A | Employee Stock Option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2024 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | P | Common Stock | 20000 | $1.81 | 136,548.0000 | 0 | 17.16% | 0.00% |
| Feb. 5, 2024 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Restricted Stock Unit | 10375 | $0.00 | 20,750.0000 | 0 | 33.33% | 0.00% |
| Feb. 5, 2024 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | M | Common stock | 10375 | $0.00 | 116,548.0000 | 0 | 9.77% | 0.00% |
| Jan. 5, 2024 | aTYR PHARMA INC | $ATYR | Shukla Sanjay | President and CEO | A | Employee Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |